Skip to main content
. 2024 Mar 21;46(5):4225–4242. doi: 10.1007/s11357-024-01124-0

Fig. 1.

Fig. 1

Cohort stratification by age, CMV and EBV serostatus and anti-CMV antibody response magnitude in relation to expected relationship to CMV exposure and reactivation